Bioprocess Development Forum - Insights, Solutions, and Shortcuts in Bioprocessing
Sponsored by GE Healthcare
Subscribe to Enews
Join LinkedIn Group
Share This Page
December 16, 2019
A Continuous Confidence Boost
GE Healthcare Life Sciences
Continuous processing of monoclonal antibodies (mAb) could offer a number of advantages, but regulatory uncertainty and upfront investment remain sticking points.
In this case study, Shanghai Henlius Biotech describes its approach to continuous mAb bioprocessing. Insights, experiences, and challenges addressed from their implementation are shared.
to read the article
Podcast: Solving Tomorrow's Downstream Processing Challenges
Unifying Continuous Biomanufacturing Operations
Continuous Processing for the Production of Biopharmaceuticals
The use of dynamic control in periodic counter-current chromatography
A Next Generation Protein A Chromatography Resin for Improved Productivity and Bioburden Control
See All Articles…
© 2020 MJH Associates. All rights reserved.